Fluor awarded more than $1 billion in life sciences contracts
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
This transformation will enable GE HealthCare to build a strong foundation for business growth
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Subscribe To Our Newsletter & Stay Updated